(Lubrizol), a subsidiary of Berkshire-Hathaway, announced today that it has acquired Vesta,
a manufacturer of medical devices, which includes disposable silicone accessories for injection,
in vitro diagnostic reagents, Covering heart disease, urology, wound care and other fields,
in addition to medical equipment and equipment services. Berkshire did not disclose the details
of the transaction.
Lubrizol is the world's leading manufacturer of specialty chemicals and chemical additives,
and its products are widely used in consumer and industrial applications. Berkshire spent $ 9
billion in 2011 to buy the company. "The acquisition of Vesta significantly strengthens the
company's strength in the field of life sciences," said Lange, head of life sciences at Lubrizol.
Vesta's professionalism will "give us the ability to provide more valuable services."
Berkshire has been involved in the field of health care. Over the past two years, Berkshire has
been holdings of the US kidney dialysis service provider Davita's stock. According to Bloomberg
data, the current Berkshire holding Davita's outstanding shares as high as 18%. Davita is a
leading provider of kidney care in the United States, providing dialysis services for patients
with chronic renal failure and end-stage renal disease.
Berkshire's earnings report on Friday showed a 41 percent year-on-year rise in profits in the
second quarter, up from $ 55.5 billion in cash and cash equivalents at the end of the second
quarter. All along, Buffett has expressed interest in large-scale mergers and acquisitions.
Zhejiang Geyi Medical Instrument Co., Ltd.
Address: No. 190 Chutian Road, Xixing Street, Binjiang Zone, Hangzhou, Zhejiang, China
General Manager: Vincent Peng